Literature DB >> 27669336

Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.

Martin Merschhemke1, Davorka Tomic1, Norman Putzki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27669336     DOI： 10.1001/jamaneurol.2016.3199

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  1 in total

1.  Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal.

Authors:  Victor Gomez-Mayordomo; Paloma Montero-Escribano; Jordi A Matías-Guiu; Nuria González-García; Jesús Porta-Etessam; Jorge Matías-Guiu
Journal:  J Med Virol       Date:  2020-07-15       Impact factor: 20.693
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.